These Numbers Could Change Investor Views For Fulcrum Therapeutics Inc (NASDAQ: FULC)
Currently, there are 53.94M common shares owned by the public and among those 45.46M shares have been available to trade. The company’s stock has a 5-day price change of -9.38% and 9.39% over the past three months. FULC shares are trading -15.74% year to date (YTD), with the 12-month market performance down to -45.60% lower. […]
